{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_0", "document_index": 69, "latency_s": 0.7151804999884916, "prompt_toks": 5229, "completion_toks": 77}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine\n\nSkull and crossbones darktextred2.png\n\nFatal overdose may occur when opiates are combined with other depressants such as benzodiazepines, barbiturates, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances.[1]\n\nIt is strongly discouraged to combine these substances, particularly in common to heavy doses.\n\nSummary sheet: Buprenorphine\n\nBuprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n\n                    Context: \n                    This excerpt provides a safety warning about buprenorphine, highlighting the risk of fatal overdose when combined with other depressants, and offers a brief overview of buprenorphine as a semisynthetic opioid and receptor modulator. It forms part of the broader drug profile detailing the pharmacology, effects, harm potential, and legal status of buprenorphine.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_1", "document_index": 69, "latency_s": 0.9199692999973195, "prompt_toks": 5443, "completion_toks": 88}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine  Purpose Chemical Nomenclature Common names Buprenex, Subutex, Butrans, Cizdol, Addnok, Transtec Systematic name (2S)-2-[(5R,6R,7R,14S)-9α-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol Class Membership Psychoactive class Opioid Chemical class Morphinan Routes of Administration WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section . ⇣ Sublingual Dosage Bioavailability 30% [2] Threshold <=0.3 mg Light 1 - 2 mg Common 2 - 4 mg Strong 4 - 8 mg Heavy 8mg + Duration Total 18 - 24 hours Onset 40 - 80 minutes Peak 1.5 - 2 hours After effects 1 - 3 days ⇣ Insufflated Dosage Bioavailability 48% [3] Threshold < 0.2 mg Light 0.2 - 0.4 mg Common 0.4 - 0.8 mg Strong 0.8 - 1.5 mg Heavy 1.5 mg + Duration Total 8 - 14 hours Onset 30 - 60 minutes Peak 4 - 8 hours After effects 1 - 3 days DISCLAIMER : PW's dosage information is\n\n\n                    Context: \n                    This section provides detailed information on buprenorphine's purpose, chemical nomenclature, common names, chemical structure, and routes of administration, including specific dosage, bioavailability, onset, peak, duration, and effects for sublingual and insufflated methods. It is a key reference for understanding the drug's pharmacological profile within the broader context of its effects, risks, and harm reduction considerations discussed in the full document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_2", "document_index": 69, "latency_s": 0.885297900007572, "prompt_toks": 5243, "completion_toks": 60}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    0.2 - 0.4 mg Common 0.4 - 0.8 mg Strong 0.8 - 1.5 mg Heavy 1.5 mg + Duration Total 8 - 14 hours Onset 30 - 60 minutes Peak 4 - 8 hours After effects 1 - 3 days DISCLAIMER : PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. Interactions MAOIs Nitrous PCP Stimulants Alcohol Benzodiazepines DXM GHB GBL Ketamine MXE Tramadol Grapefruit\n\n\n                    Context: \n                    This excerpt presents specific dosage ranges, onset, peak, and duration information for sublingual buprenorphine, emphasizing the importance of responsible use and potential drug interactions. It is a critical part of the broader medication profile, aiding in safe administration and understanding of effects within the full drug summary.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_3", "document_index": 69, "latency_s": 0.7319514999981038, "prompt_toks": 5346, "completion_toks": 80}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    At higher dosages, it is used to treat opioid addiction in opioid-dependent individuals. In lower dosages it is used to control moderate-acute pain in non-opioid-tolerant individuals and in even lower dosages it is used to control moderate chronic pain.\n\nBuprenorphine was patented in 1965, and approved for medical use in the United States in 1981.[4] In 2017, 14.6 million prescriptions for the medication were written in the United States.[5] It is also a common medication used to treat opioid use disorders, such as addiction to heroin.[5] Buprenorphine may also be used recreationally by injection or intranasally for the high it produces.[5]\n\nContents\n\n1 Chemistry\n\n2 Pharmacology\n\n3 Subjective effects\n\n3.1 Physical effects\n\n3.2 Cognitive effects\n\n3.3 Visual effects\n\n3.3.1 Hallucinatory states\n\n3.4 Experience reports\n\n4 Toxicity and harm potential\n\n4.1 Tolerance and addiction potential\n\n4.2 Precipitated withdrawal syndrome\n\n4.3 Dangerous interactions\n\n5 Legal status\n\n6 See also\n\n\n                    Context: \n                    This section provides an overview of buprenorphine’s medical uses at different dosages, its patent history, and prescription statistics in the U.S., highlighting its role in opioid addiction treatment and recreational use. It also outlines the document’s structure, including chemistry, pharmacology, subjective effects, and legal status, situating the detailed drug profile within the broader context of its medical and recreational implications.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_4", "document_index": 69, "latency_s": 0.5992058999981964, "prompt_toks": 5299, "completion_toks": 61}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    3.4 Experience reports\n\n4 Toxicity and harm potential\n\n4.1 Tolerance and addiction potential\n\n4.2 Precipitated withdrawal syndrome\n\n4.3 Dangerous interactions\n\n5 Legal status\n\n6 See also\n\n7 External links\n\n8 References\n\nChemistry\n\nBuprenorphine is a semi-synthetic morphinan derivative of the opioid alkaloid thebaine. Like many opioids, such as codeine or hydrocodone, it is has a morphinan backbone.\n\nBuprenorphine and other molecules of this class contain a polycyclic core of three benzene rings fused in a zig-zag pattern called phenanthrene. A fourth nitrogen containing ring is fused to the phenanthrene at R9 and R13. Buprenophine (along with other morphinans) contains an ether bridge between two of its rings, connecting the benzene and opposite cyclohexane ring through an oxygen group.\n\n\n                    Context: \n                    This chunk covers the subjective effects, toxicity, addiction potential, withdrawal, dangerous interactions, and chemical structure of buprenorphine, providing detailed insights into its psychoactive profile, harm risks, legal classification, and chemical properties, essential for understanding its use and risks as outlined in the full drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_5", "document_index": 69, "latency_s": 0.5346902000019327, "prompt_toks": 5269, "completion_toks": 41}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine is unique to human medical opioids as it contains an addition fused ring which connects to the lower cyclohexane ring at R6 and R14. This structure is called a endoethenotetrahydrooripavine backbone, often found in veterinarian opioids. It contains a hydroxy group (OH-) substituted on the benzene ring and a methoxy group bound to the lower cyclohexane ring. The backbone of buprenorphine is also substituted with a methyl cyclopropyl moeity on its amino group. Adjacent to its methoxy attachment, the cyclohexane ring is bonded to R2 of a 2-butanol chain.\n\nPharmacology\n\nThis pharmacology section is incomplete. You can help by adding to it.\n\n\n                    Context: \n                    This excerpt describes the unique chemical structure of buprenorphine, including its fused ring system and specific molecular substitutions, providing detailed chemistry information crucial for understanding its pharmacological properties discussed later in the document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_6", "document_index": 69, "latency_s": 0.698173400000087, "prompt_toks": 5303, "completion_toks": 62}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Pharmacology\n\nThis pharmacology section is incomplete. You can help by adding to it.\n\nBuprenorphine acts as a partial agonist of the μ-opioid receptor with a binding affinity of Ki = 1.5 nM in contrast to full agonists like morphine. It also acts as an antagonist of the κ-opioid receptor with a binding affinity of Ki = 2.5 nM and the δ-opioid receptor with a binding affinity of Ki = 6.1 nM. The ratio of these binding affinities is important, if you compare morphine's binding ratio of 1:50:176 to Buprenorphine's ratio of 15:25:61, it is apparent that the side-effect profile will be much higher to Buprenorphine and μ-opioid stimulation for euphoric effects, sequentially the drug will also bind to delta and kappa opioid receptors to a comparatively high degree.\n\n\n                    Context: \n                    This section provides detailed pharmacological data on buprenorphine's receptor binding affinities and its role as a partial μ-opioid receptor agonist and κ- and δ-opioid receptor antagonist, highlighting its unique receptor activity profile and implications for effects and side effects within the overall drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_7", "document_index": 69, "latency_s": 0.6536694999958854, "prompt_toks": 5282, "completion_toks": 82}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine exerts its effects by binding to and activating the μ-opioid receptor. This occurs because opioids structurally mimic endogenous endorphins which are naturally found within the body and also work upon the μ-opioid receptor set. The way in which opioids structurally mimic these natural endorphins results in their euphoria, pain relief and anxiolytic effects. This is because endorphins are responsible for reducing pain, causing sleepiness, and feelings of pleasure. They can be released in response to pain, strenuous exercise, orgasm, or general excitement.\n\nSubjective effects\n\nDisclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.\n\n\n                    Context: \n                    This excerpt explains how buprenorphine binds to the μ-opioid receptor to produce its effects, highlighting the mechanism behind its euphoria, pain relief, and anxiolytic properties. It provides fundamental pharmacological information crucial for understanding the drug's subjective and physical effects discussed later in the document. The section also introduces the subjective effects section, which relies on anecdotal reports to describe user experiences.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_8", "document_index": 69, "latency_s": 0.7697366000065813, "prompt_toks": 5309, "completion_toks": 91}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.\n\nPhysical effects\n\nPain relief\n\nPhysical euphoria - This particular substance can be considered as less intense in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin) due to it being a partial agonist of the μ-opioid receptor. The sensation itself can be described as extreme feelings of intense physical comfort, warmth and bliss which spreads throughout the body.\n\nItchiness\n\nRespiratory depression - Buprenorphine causes less respiratory depression than other opioids due to it being a partial agonist of the μ-opioid receptor.\n\nDizziness\n\nSedation\n\nDecreased heart rate\n\nConstipation\n\nCough suppression\n\nDecreased libido\n\nDifficulty urinating\n\n\n                    Context: \n                    This section details the physical effects and risks of buprenorphine, emphasizing its less severe respiratory depression compared to other opioids and outlining common physiological effects such as pain relief, euphoria, and side effects like itchiness and decreased libido. It highlights that adverse effects and the spectrum of effects are dose-dependent and may become more severe at higher doses, providing essential safety information within the comprehensive overview of buprenorphine's pharmacology and harm potential.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_9", "document_index": 69, "latency_s": 0.6457093999924837, "prompt_toks": 5308, "completion_toks": 52}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Dizziness\n\nSedation\n\nDecreased heart rate\n\nConstipation\n\nCough suppression\n\nDecreased libido\n\nDifficulty urinating\n\nPupil constriction\n\nNausea - Buprenorphine causes substantially more nausea and vomiting than other opioids.\n\nAppetite suppression\n\nOrgasm suppression\n\nCognitive effects\n\nThe general head space of buprenorphine is described by many as one of euphoria, relaxation, anxiety suppression and pain relief.\n\nCognitive euphoria - This particular substance can be considered as less intense in its cognitive euphoria when compared with that of morphine or diacetylmorphine (heroin) due to it being a partial agonist of the μ-opioid receptor. It is still, however, capable of extreme intensity and overwhelming bliss at heavier dosages with a low tolerance. The sensation itself can be described as powerful and overwhelming feeling of emotional bliss, contentment, and happiness.\n\nAnxiety suppression\n\nVisual effects\n\nHallucinatory states\n\n\n                    Context: \n                    This section details the subjective physical, cognitive, and visual effects of buprenorphine, including sensations of euphoria, relaxation, anxiety suppression, and potential hallucinations, providing essential information on its psychoactive profile and user experience within the broader drug overview.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_10", "document_index": 69, "latency_s": 0.7758878000022378, "prompt_toks": 5310, "completion_toks": 85}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Anxiety suppression\n\nVisual effects\n\nHallucinatory states\n\nInternal hallucination - One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery. This is often accompanied by ill-defined geometry.\n\nExperience reports\n\nThere are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:\n\nErowid Experience Vaults: Buprenorphine\n\nToxicity and harm potential\n\nTable from the 2010 ISCD study ranking various drugs (legal and illegal) based on statements by drug-harm experts. Buprenorphine was found to be the 19th overall most dangerous drug.[6]\n\nA 2007 assessment of harm from recreational drug use (mean physical harm and mean dependence liability): Buprenorphine was ranked 9th in dependence, 8th in physical harm, and 11th in social harm.[7]\n\n\n                    Context: \n                    This snippet provides detailed information on buprenorphine’s subjective effects, including anxiety suppression, visual hallucinations, and internal hallucinations, as well as references to user experience reports. It also discusses the drug’s toxicity and harm potential, highlighting its ranking in drug danger assessments. This content is relevant for understanding buprenorphine's psychoactive profile, safety considerations, and harm ranking within the drug's comprehensive profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_11", "document_index": 69, "latency_s": 0.6682621000072686, "prompt_toks": 5278, "completion_toks": 69}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    A 2007 assessment of harm from recreational drug use (mean physical harm and mean dependence liability): Buprenorphine was ranked 9th in dependence, 8th in physical harm, and 11th in social harm.[7]\n\nBuprenorphine has a low toxicity relative to dose: the ceiling dose for buprenorphine is usually between 16mg and 32mg, and anything above this will not produce an increase in respiratory depression (the primary cause of death in opioid overdose is severe respiratory depression, leading to respiratory collapse). Thus increasing the dose of buprenorphine above this level will not continue to increase risk of death in a fashion similar to other μ-opioid receptor agonists. As with all opioids, long-term effects can vary but can include diminished libido, apathy and memory loss.\n\n\n                    Context: \n                    This excerpt provides information on the harm ranking and toxicity profile of buprenorphine, highlighting its relatively low danger compared to other opioids, with a ceiling dose that limits respiratory depression and associated risks. It situates these safety considerations within the broader discussion of buprenorphine's effects, toxicity, and harm potential outlined in the document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_12", "document_index": 69, "latency_s": 0.6370021000038832, "prompt_toks": 5292, "completion_toks": 55}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Regardless of the ceiling dose, an important distinction has to be made in the dose used in opioid naive individuals and opioid experienced individuals. Even low doses in individuals with no tolerance can cause unpleasant side-effects like dizziness, loss of balance, and vomiting. Because of the long half-life of buprenorphine, these side-effects can last a long while in opioid naive individuals which creates the risk of severe dehydration from uncontrollable vomiting.\n\nBuprenorphine is often sold under the brand name Suboxone, which also contains naloxone. Naloxone is not orally active except at higher doses, so when large amounts of Suboxone are taken, the naloxone takes effect and reverses the effects of the buprenorphine. This is done to deter abuse of Suboxone.\n\nIt is strongly recommended that one use harm reduction practices when using this drug.\n\nTolerance and addiction potential\n\n\n                    Context: \n                    This section discusses the dosing considerations and safety measures for buprenorphine, highlighting differences between opioid-naive and experienced users, the role of naloxone in sublingual formulations like Suboxone to prevent abuse, and emphasizes the importance of harm reduction practices.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_13", "document_index": 69, "latency_s": 0.5900251999992179, "prompt_toks": 5183, "completion_toks": 54}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    It is strongly recommended that one use harm reduction practices when using this drug.\n\nTolerance and addiction potential\n\nAs with other opioids, the chronic use of buprenorphine can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal symptoms may occur if a person suddenly stops their usage.\n\n\n                    Context: \n                    This chunk provides essential harm reduction advice and information on buprenorphine's addiction potential, highlighting the importance of safe use practices and outlining the risks of dependency associated with chronic use, which are key considerations within the broader discussion of drug effects, risks, and safety.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_14", "document_index": 69, "latency_s": 0.6173579999885987, "prompt_toks": 5251, "completion_toks": 54}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Tolerance to many of the effects of buprenorphine develops with prolonged and repeated use. The rate at which this occurs develops at different rates for different effects, with tolerance to the constipation-inducing effects developing particularly slowly for instance. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Buprenorphine presents cross-tolerance with all other opioids, meaning that after the consumption of buprenorphine all opioids will have a reduced effect.\n\nPrecipitated withdrawal syndrome\n\n\n                    Context: \n                    This section discusses buprenorphine's tolerance development and its potential to cause precipitated withdrawal syndrome, highlighting the risks associated with repeated use, dose escalation, and abrupt cessation, which are critical for understanding its safety profile within the broader harm potential and addiction risk analysis.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_15", "document_index": 69, "latency_s": 0.7355537000112236, "prompt_toks": 5278, "completion_toks": 72}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Precipitated withdrawal syndrome\n\nBuprenorphine has the ability to precipitate withdrawal symptoms in opiate-dependent individuals. This is due to buprenorphine only being a partial agonist, which does not activate the receptor with the appreciable efficacy of a full agonist, as well as having a very high binding affinity for the μ-opioid receptor (Ki = 1.5nM), displacing other agonists that may still be attached when the buprenorphine is ingested.\n\nNote: It is a common misconception that naloxone, in some buprenorphine formulations, is what causes the precipitated withdrawal syndrome to manifest. This is false, as naloxone has a lower binding than Buprenorphine, as well as being inactive through most routes of administration.\n\nDangerous interactions\n\n\n                    Context: \n                    This section explains buprenorphine's potential to induce precipitated withdrawal in opioid-dependent users due to its high receptor affinity and partial agonist activity, clarifying common misconceptions about naloxone's role. It is relevant for understanding withdrawal risks and drug interactions within the comprehensive overview of buprenorphine's effects, safety, and harm potential.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_16", "document_index": 69, "latency_s": 1.0096397000015713, "prompt_toks": 5255, "completion_toks": 57}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Dangerous interactions\n\nWarning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).\n\nAlways conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.\n\nAlcohol - Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. Place affected patients in the recovery position to prevent vomit aspiration from excess. Memory blackouts are likely\n\n\n                    Context: \n                    This excerpt from the full document details dangerous interactions between buprenorphine and other psychoactive substances, highlighting risks such as enhanced sedation, loss of consciousness, and aspiration. It provides crucial harm reduction information relevant to safe use, emphasizing the importance of independent research before combining substances.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_17", "document_index": 69, "latency_s": 0.7167835000000196, "prompt_toks": 5269, "completion_toks": 76}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Stimulants - Stimulants increase respiration rate which allows for a higher dose of opiates than would otherwise be used. If the stimulant wears off first then the opiate may overcome the user and cause respiratory arrest.\n\nBenzodiazepines - Central nervous system and/or respiratory-depressant effects may be additively or synergistically present. The two substances potentiate each other strongly and unpredictably, very rapidly leading to unconsciousness. While unconscious, vomit aspiration is a risk if not placed in the recovery position blackouts/memory loss likely.\n\nDXM - Generally considered to be toxic. CNS depression, difficulty breathing, heart issues, and liver toxicity have been observed. Additionally if one takes DXM, their tolerance of opiates goes down slightly, thus causing additional synergistic effects.\n\n\n                    Context: \n                    This section details dangerous drug interactions with buprenorphine, highlighting the synergistic risks when combined with stimulants, benzodiazepines, and DXM, including respiratory depression, unconsciousness, and toxicity concerns. It emphasizes the importance of understanding these interactions for harm reduction and safe use within the broader context of buprenorphine's pharmacology and risks.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_18", "document_index": 69, "latency_s": 0.8163529000012204, "prompt_toks": 5302, "completion_toks": 71}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    GHB/GBL - The two substances potentiate each other strongly and unpredictably, very rapidly leading to unconsciousness. While unconscious, vomit aspiration is a risk if not placed in the recovery position\n\nKetamine - Both substances bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.\n\nMAOIs - Coadministration of monoamine oxidase inhibitors (MAOIs) with certain opioids has been associated with rare reports of severe adverse reactions. There appear to be two types of interaction, an excitatory and a depressive one. Symptoms of the excitatory reaction may include agitation, headache, diaphoresis, hyperpyrexia, flushing, shivering, myoclonus, rigidity, tremor, diarrhea, hypertension, tachycardia, seizures, and coma. Death has occurred in some cases.\n\n\n                    Context: \n                    This section details dangerous drug interactions involving opioids, including potentiation of effects and risks of unconsciousness and aspiration when combining substances like GHB/GBL, ketamine, and MAOIs. It highlights the severity of these interactions and the importance of caution with poly-drug use, aligning with the document’s focus on harm reduction and safety considerations.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_19", "document_index": 69, "latency_s": 0.6834578999987571, "prompt_toks": 5252, "completion_toks": 73}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    MXE - MXE can potentiate the effects of opioids but also increases the risk of respiratory depression and organ toxicity.\n\nNitrous - Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position. Memory blackouts are common.\n\nPCP - PCP may reduce opioid tolerance, increasing the risk of overdose.\n\nTramadol - Increased risk of seizures. Tramadol itself is known to induce seizures and it may have additive effects on seizure threshold with other opioids. Central nervous system- and/or respiratory-depressant effects may be additively or synergistically present.\n\n\n                    Context: \n                    This section details dangerous drug interactions between buprenorphine and specific substances, highlighting risks such as respiratory depression, organ toxicity, loss of consciousness, increased overdose potential, seizures, and additive sedative effects. It is a crucial part of the harm reduction and safety information within the full document on buprenorphine, emphasizing the importance of avoiding certain combinations.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_20", "document_index": 69, "latency_s": 0.862210999999661, "prompt_toks": 5318, "completion_toks": 101}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Grapefruit - While grapefruit is not psychoactive, it may affect the metabolism of certain opioids. Tramadol, oxycodone, and fentanyl are all primarily metabolized by the enzyme CYP3A4, which is potently inhibited by grapefruit juice[8]. This may cause the drug to take longer to clear from the body. it may increase toxicity with repeated doses. Methadone may also be affected[8]. Codeine and hydrocodone are metabolized by CYP2D6. People who are on medicines that inhibit CYP2D6, or that lack the enzyme due to a genetic mutation will not respond to codeine as it can not be metabolized into its active product: morphine.\n\nLegal status\n\nThis legality section is a stub . As such, it may contain incomplete or wrong information. You can help by expanding it .\n\nIn the European Union, buprenorphine can be prescribed either alone or in combination with another substance and is approved for the treatment of opioid addiction.[9]\n\n\n                    Context: \n                    This section discusses how grapefruit can influence the metabolism of certain opioids such as tramadol, oxycodone, fentanyl, and methadone by inhibiting the CYP3A4 enzyme, affecting drug clearance and toxicity. It also notes that codeine and hydrocodone's activation depends on CYP2D6 activity, which can vary due to genetic factors or drug interactions. The content is relevant to harm reduction and drug interaction considerations within the broader context of opioid pharmacology and legality.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_21", "document_index": 69, "latency_s": 0.8847902999987127, "prompt_toks": 5334, "completion_toks": 91}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    In the European Union, buprenorphine can be prescribed either alone or in combination with another substance and is approved for the treatment of opioid addiction.[9]\n\nAustria: Buprenorphine is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich).[citation needed]\n\nCanada: Buprenorphine is a schedule I substance in Canada and is only available with a valid prescription. [10]\n\nGermany: Buprenorphine is controlled under Anlage III BtMG (Narcotics Act, Schedule III)[11] as of September 1, 1984.[12] It can only be prescribed on a narcotic prescription form.\n\nNetherlands: Buprenorphine a List II drug of the Opium Law, although special rules apply to its prescription and dispensation.[citation needed]\n\nRussia: Buprenorphine is a Schedule II controlled substance.[13]\n\nSweden: Buprenorphine is a class IV controlled substance.[14]\n\n\n                    Context: \n                    This excerpt provides an overview of the legal status of buprenorphine in various countries, detailing its regulation, prescription requirements, and classification within the European Union, Canada, Germany, the Netherlands, Russia, and Sweden. It complements the main document's comprehensive information on buprenorphine by highlighting international legal frameworks and restrictions relevant to its medical and recreational use. Such legal details are essential for understanding the substance's accessibility and regulatory context worldwide.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_22", "document_index": 69, "latency_s": 0.7189594000083162, "prompt_toks": 5204, "completion_toks": 70}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Russia: Buprenorphine is a Schedule II controlled substance.[13]\n\nSweden: Buprenorphine is a class IV controlled substance.[14]\n\nSwitzerland: Buprenorphine is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.[15]\n\nUnited States: Buprenorphine, either alone or in combination with naloxone (as, for example, Suboxone), is a Schedule III drug.[citation needed]\n\n\n                    Context: \n                    This section outlines the legal status of buprenorphine across various countries, detailing its classification and scheduling. It highlights differing regulations in Russia, Sweden, Switzerland, and the United States, emphasizing its controlled substance status and permitted medical use. This information is relevant for understanding the legal context and regulatory risks associated with buprenorphine use worldwide.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_23", "document_index": 69, "latency_s": 0.7398202000040328, "prompt_toks": 5319, "completion_toks": 93}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    United States: Buprenorphine, either alone or in combination with naloxone (as, for example, Suboxone), is a Schedule III drug.[citation needed]\n\nPrior to the approval of Suboxone in the U.S. for treating opioid addiction, the Drug Addiction Treatment Act of 2000 was passed. This law gives the Secretary of Health and Human Services the authority to grant a waiver to all physicians with appropriate training to prescribe and administer narcotics from Schedules III-V in the treatment of drug addiction. Prior to the passage of this law such authority was restricted solely to physicians working in an outpatient clinic specifically designed for treatment of addiction. The waiver, which requires the physician to undergo an 8-hour training course, initially allowed that physician to treat only 10 patients in this manner; as of 2016, this limit has been increased to 275.[16]\n\nSee also\n\nResponsible use\n\nDepressants\n\nOxycodone\n\nKratom\n\nExternal links\n\nBuprenorphine (Wikipedia)\n\n\n                    Context: \n                    This excerpt details the legal status and regulatory framework for buprenorphine in the United States, highlighting its scheduling as a Schedule III drug, the Drug Addiction Treatment Act of 2000, and prescribing restrictions. It situates the medication's legal classification within the broader context of harm reduction, medical use, and responsible administration discussed throughout the full document. The information is crucial for understanding the legal and medical context of buprenorphine usage and prescription guidelines.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_24", "document_index": 69, "latency_s": 0.6933136000006925, "prompt_toks": 5431, "completion_toks": 75}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    See also\n\nResponsible use\n\nDepressants\n\nOxycodone\n\nKratom\n\nExternal links\n\nBuprenorphine (Wikipedia)\n\nBuprenorphine (Erowid Vault)\n\nBuprenorphine (Isomer Design)\n\nBuprenorphine (DrugBank)\n\nBuprenorphine (Drugs.com)\n\nBuprenorphine (Drugs-Forum)\n\nReferences\n\n↑ Risks of Combining Depressants - TripSit\n\n↑ Mendelson, J., Upton, R. A., Everhart, E. T., Jacob, P., Jones, R. T. (January 1997). \"Bioavailability of sublingual buprenorphine\". Journal of Clinical Pharmacology. 37 (1): 31–37. doi:10.1177/009127009703700106. ISSN 0091-2700.\n\n↑ Eriksen, J., Jensen, N. H., Kamp-Jensen, M., Bjarnø, H., Friis, P., Brewster, D. (November 1989). \"The systemic availability of buprenorphine administered by nasal spray\". The Journal of Pharmacy and Pharmacology. 41 (11): 803–805. doi:10.1111/j.2042-7158.1989.tb06374.x. ISSN 0022-3573.\n\n↑ Fischer, J., Ganellin, C. R. (2006). Analogue-based drug discovery. Wiley-VCH. ISBN 9783527607495.\n\n\n                    Context: \n                    This chunk completes the \"See also\" and \"References\" sections of the full webpage on buprenorphine, providing links to related substances, external resources, and citations for safety, pharmacology, and bioavailability studies relevant to understanding the drug's legal status, effects, and harm potential. It is essential for comprehensive reference and further reading within the drug information context.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_25", "document_index": 69, "latency_s": 0.7123431000072742, "prompt_toks": 5370, "completion_toks": 67}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    ↑ Fischer, J., Ganellin, C. R. (2006). Analogue-based drug discovery. Wiley-VCH. ISBN 9783527607495.\n\n↑ 5.0 5.1 5.2 Buprenorphine, Substance Abuse and Mental Health Services Administration, retrieved July 29, 2019\n\n↑ Nutt DJ, King LA, Phillips LD (November 2010). \"Drug harms in the UK: a multicriteria decision analysis\". Lancet. 376 (9752): 1558–1565. CiteSeerX 10.1.1.690.1283 . doi:10.1016/S0140-6736(10)61462-6. PMID 21036393. Unknown parameter |s2cid= ignored (help)\n\n↑ Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). \"Development of a rational scale to assess the harm of drugs of potential misuse\". Lancet. 369 (9566): 1047–1053. doi:10.1016/S0140-6736(07)60464-4. PMID 17382831. Unknown parameter |s2cid= ignored (help)\n\n\n                    Context: \n                    This information provides key references and sources supporting the pharmacological and harm assessment sections of the buprenorphine page, including citation details from scientific literature and authoritative agencies. It enhances the credibility of the content and aids in source verification for users seeking detailed research backing about buprenorphine's effects, risks, and harm potential.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_26", "document_index": 69, "latency_s": 0.6522767999995267, "prompt_toks": 5447, "completion_toks": 64}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    ↑ 8.0 8.1 Ershad, M., Cruz, M. D., Mostafa, A., Mckeever, R., Vearrier, D., Greenberg, M. I. (March 2020). \"Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance\". Journal of Addiction Medicine. 14 (2): 172–174. doi:10.1097/ADM.0000000000000535. ISSN 1932-0620.\n\n↑ EMA (2018), Suboxone\n\n↑ Consolidated federal laws of Canada, Controlled Drugs and Substances Act, 2022\n\n↑ \"Anlage III BtMG\" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 18, 2019.\n\n↑ \"Erste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften\" (PDF). Bundesgesetzblatt Jahrgang 1984 Teil I Nr. 36 (in German). Bundesanzeiger Verlag. August 8, 1984. Retrieved December 18, 2019.\n\n↑ Постановление Правительства РФ от 01.10.2012 N 1002 (ред. от 09.08.2019)\n\n↑ Läkemedelsverkets föreskrifter (LVFS 1997:12) om förteckningar över narkotika, konsoliderad version t.o.m. LVFS 2010:1\n\n\n                    Context: \n                    This excerpt lists references related to the legal status and regulatory information of buprenorphine across multiple countries, including German, Canadian, Russian, and Swedish laws, as well as studies on drug interactions such as grapefruit juice effects. It provides source citations supporting the legal classification and safety considerations discussed in the main document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "num_chunks": 28, "chunk_id": "69::chunk_27", "document_index": 69, "latency_s": 0.6557750999927521, "prompt_toks": 5311, "completion_toks": 64}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    ↑ Постановление Правительства РФ от 01.10.2012 N 1002 (ред. от 09.08.2019)\n\n↑ Läkemedelsverkets föreskrifter (LVFS 1997:12) om förteckningar över narkotika, konsoliderad version t.o.m. LVFS 2010:1\n\n↑ \"Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien\" (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.\n\n↑ Jacobs, H., The Obama administration made a change that could have a huge effect on the opioid epidemic\n\nRetrieved from ‘https://psychonautwiki.org/w/index.php?title=Buprenorphine&oldid=165586’\n\n\n                    Context: \n                    This chunk provides references to legal and regulatory documents from Russia, Sweden, and Switzerland, as well as a related citation about policy impacts on the opioid epidemic. It is part of the legal status section of the full document, offering specific sources and regulatory updates relevant to buprenorphine's legal classification in multiple countries.\n                "}
